---
category: news
title: "Avalon GloboCare advances its AI-enhanced protein design technology for cellular therapy development in collaboration with MIT"
excerpt: "The researchers used the QTY code technology to design water-soluble versions of chemokine receptorsâ€”water-insoluble proteins involved"
publishedDateTime: 2021-12-09T14:20:00Z
originalUrl: "https://www.proactiveinvestors.com/companies/news/968784/avalon-globocare-advances-its-ai-enhanced-protein-design-technology-for-cellular-therapy-development-in-collaboration-with-mit-968784.html"
webUrl: "https://www.proactiveinvestors.com/companies/news/968784/avalon-globocare-advances-its-ai-enhanced-protein-design-technology-for-cellular-therapy-development-in-collaboration-with-mit-968784.html"
ampWebUrl: "https://www.proactiveinvestors.com/companies/amp/news/968784"
cdnAmpWebUrl: "https://www-proactiveinvestors-com.cdn.ampproject.org/c/s/www.proactiveinvestors.com/companies/amp/news/968784"
type: article
quality: 46
heat: 46
published: false

provider:
  name: Proactiveinvestors
  domain: proactiveinvestors.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.proactiveinvestors.com//thumbs/upload/News/Image/2021_12/1200z740_1639060784_shutterstock_530971462.jpg"
    width: 1200
    height: 740
    isCached: true

secured: "wLSZVBQiFXeheaF7nBUp5YKlOzOzOX+Tt/5wE7JTAznkN1C+gvRLXz3GPUpbitm+udPw7L7bO8AwYYdRWYsz1E0JsbP/r6AlGJW/hNPXB8rU56xw9WyeFv0/yyikRp0H/JKWyy+tKywJ+jrHMa5QqwLU77VGJZ65C5NBQo3YeGOjHDcYLkQuks2zMWH+FD/xs+NmP9hF26qENrgIsUt/NiaJ2aponPYKWtCl+2X98mmtuzp4kGuOuQe2Q+U5q8HMY9lIhVrQ+vCL99uhjE5s27BeJEgucnwKKQ7UH0vd5TU/lXQsQLY0M6W6y6c9xajasD5+StBSqsvOjGHLvNlV77kvfcw3oYMi4Hxws4kzG6o=;xOizDhX4AxZ/6ttkK3MJbg=="
---

